These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 14986883

  • 1. The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation.
    Bódi A, Szilágyi S, Edes I, Papp Z.
    Gen Physiol Biophys; 2003 Sep; 22(3):313-27. PubMed ID: 14986883
    [Abstract] [Full Text] [Related]

  • 2. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ.
    Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
    [Abstract] [Full Text] [Related]

  • 3. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
    Kaheinen P, Pollesello P, Hertelendi Z, Borbély A, Szilágyi S, Nissinen E, Haikala H, Papp Z.
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
    [Abstract] [Full Text] [Related]

  • 4. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G, Pieske B, Kretschmann B, Holubarsch C, Alpert NR, Just H.
    J Cardiovasc Pharmacol; 1995 Jan; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [Abstract] [Full Text] [Related]

  • 5. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN, Christ T, Rasche B, Rasche S, Wettwer E, Deussen A, Ravens U, Koch T, Hübler M.
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [Abstract] [Full Text] [Related]

  • 6. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H, Kaheinen P, Levijoki J, Lindén IB.
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [Abstract] [Full Text] [Related]

  • 7. The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts.
    Kristof E, Szigeti G, Papp Z, Bodi A, Ball NA, Walsh RA, Edes I.
    Basic Res Cardiol; 1999 Aug; 94(4):223-30. PubMed ID: 10505421
    [Abstract] [Full Text] [Related]

  • 8. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
    Sato S, Talukder MA, Sugawara H, Sawada H, Endoh M.
    J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
    [Abstract] [Full Text] [Related]

  • 9. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
    Nagy L, Pollesello P, Haikala H, Végh Á, Sorsa T, Levijoki J, Szilágyi S, Édes I, Tóth A, Papp Z, Papp JG.
    Eur J Pharmacol; 2016 Mar 15; 775():120-9. PubMed ID: 26872993
    [Abstract] [Full Text] [Related]

  • 10. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
    Szilágyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tósaki A, Borbély A, Edes I, Papp Z.
    J Cardiovasc Pharmacol; 2005 Sep 15; 46(3):369-76. PubMed ID: 16116344
    [Abstract] [Full Text] [Related]

  • 11. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig.
    Szilágyi S, Pollesello P, Levijoki J, Kaheinen P, Haikala H, Edes I, Papp Z.
    Eur J Pharmacol; 2004 Feb 13; 486(1):67-74. PubMed ID: 14751410
    [Abstract] [Full Text] [Related]

  • 12. The effects of levosimendan on [Ca2+]i in guinea-pig isolated ventricular myocytes.
    Lancaster MK, Cook SJ.
    Eur J Pharmacol; 1997 Nov 19; 339(1):97-100. PubMed ID: 9450621
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of the contractile effects of levosimendan in the mammalian heart.
    Bokník P, Neumann J, Kaspareit G, Schmitz W, Scholz H, Vahlensieck U, Zimmermann N.
    J Pharmacol Exp Ther; 1997 Jan 19; 280(1):277-83. PubMed ID: 8996207
    [Abstract] [Full Text] [Related]

  • 14. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N, Boknik P, Gams E, Herzig JW, Neumann J, Scholz H.
    Eur J Cardiothorac Surg; 1998 Jul 19; 14(1):70-5. PubMed ID: 9726618
    [Abstract] [Full Text] [Related]

  • 15. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
    Kaheinen P, Pollesello P, Levijoki J, Haikala H.
    J Cardiovasc Pharmacol; 2004 Apr 19; 43(4):555-61. PubMed ID: 15085067
    [Abstract] [Full Text] [Related]

  • 16. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B.
    Eur J Cardiothorac Surg; 2008 Aug 19; 34(2):326-31. PubMed ID: 18539040
    [Abstract] [Full Text] [Related]

  • 17. Ischemia-reperfusion injury changes the dynamics of Ca2+-contraction coupling due to inotropic drugs in isolated hearts.
    Rhodes SS, Ropella KM, Camara AK, Chen Q, Riess ML, Pagel PS, Stowe DF.
    J Appl Physiol (1985); 2006 Mar 19; 100(3):940-50. PubMed ID: 16282437
    [Abstract] [Full Text] [Related]

  • 18. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ, Si R, Zhou N, Zhang HF, Guo WY, Wang HC, Gao F.
    Apoptosis; 2008 Feb 19; 13(2):305-17. PubMed ID: 18165901
    [Abstract] [Full Text] [Related]

  • 19. Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium.
    Lochner A, Colesky F, Genade S.
    Cardiovasc Drugs Ther; 2000 Jun 19; 14(3):271-81. PubMed ID: 10935149
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium.
    Brixius K, Reicke S, Schwinger RH.
    Am J Physiol Heart Circ Physiol; 2002 Jan 19; 282(1):H131-7. PubMed ID: 11748056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.